🔎 Trials Near Me

Почетна › Akutna limfoblastna leukemija › Kolorado

Kliničke studije za Akutna limfoblastna leukemija u državi Kolorado

13 studija za Akutna limfoblastna leukemija traži učesnike na lokacijama u državi Kolorado.

Gradovi u državi Kolorado

Zvanični tekst studije (na engleskom)

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

  • Children's Hospital Colorado, Aurora
Тражи се учесникФаза 1
Узраст од 0 до 18 · Оба пола · Ажурирано 13. 11. 2026. · NCT06173518

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Rocky Mountain Regional VA Medical Center, Aurora
  • UCHealth University of Colorado Hospital, Aurora
  • Penrose-Saint Francis Healthcare, Colorado Springs
  • и још 15
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

  • Children's Hospital Colorado, Aurora
Тражи се учесникОпсервациона студија
Узраст од 0 до 38 · Оба пола · Ажурирано 29. 10. 2026. · NCT06131801

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

  • University of Colorado, Aurora
Тражи се учесникФаза 1/2
30 Days · Оба пола · Ажурирано 9. 10. 2026. · NCT04065399

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

  • Colorado Blood Cancer Institute, Denver
Тражи се учесникФаза 2
6 Months · Оба пола · Ажурирано 28. 9. 2026. · NCT06514794

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

  • Children's Hospital Colorado, Aurora
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 1. 9. 2026. · NCT07586618

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Children's Hospital Colorado, Aurora
  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
Тражи се учесникФаза 1/2
До 22 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

  • Colorado Children's Hospital, Denver
Тражи се учесникФаза 2
Узраст од 7 до 25 · Оба пола · Ажурирано 19. 8. 2026. · NCT05082519

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Children's Hospital Colorado, Aurora
  • University of Colorado Hospital, Aurora
  • Presbyterian St. Luke's/Colorado Blood Cancer Institute, Denver
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 6. 7. 2026. · NCT01351545

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  • Colorado Blood Cancer Institute, Denver
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 24. 3. 2026. · NCT04988555

Venetoclax Basket Trial for High Risk Hematologic Malignancies

  • Children's Hospital Colorado, Aurora
Тражи се учесникФаза 1
Узраст од 1 до 40 · Оба пола · Ажурирано 12. 3. 2026. · NCT05292664

UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1

  • University of Colorado Hospital, Aurora
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 11. 3. 2026. · NCT05535855

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Children's Hospital Colorado, Denver
Тражи се учесникФаза 1
Узраст од 1 до 21 · Оба пола · Ажурирано 6. 12. 2024. · NCT05476770

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.